drugset / Trial / NCT02808741

Evaluation of Immediate Release Tablet

NCT02808741

Phase 1 Completed 20 enrolled F2G Ltd Quotient Clinical · collab
RandomizedSingle-groupOpen-labelTreatment

Summary

Single dose comparison of liquid and solid formulation, followed by study of effect of high fat breakfast. Evaluation of multiple dose pharmacokinetics and tolerability

Timeline

Start
2016-07
Primary completion
2016-11
Completion
2016-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Olorofim Small molecule 360 mg Oral